Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
By M. Knowles, C. Hurst. Nature Reviews. Cancer, 2014
1,185 citations recorded by the source corpus.
Subfields: Molecular Biology, Surgery
View Paper: https://www.semanticscholar.org/paper/470a2a1f2606d3e7efd3183f24d8fa72154a9b90
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Peter W. Laird
- S. Baylin
- Gad Getz
- Matthew Meyerson
- Yiling Lu
- Benilton S. Carvalho
- John N. Weinstein
- Inanç Birol
In Surgery
Citations in the corpus
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer (2019, background): “Many chromosomal rearrangements and more than 50 oncogenes and tumor suppressor genes have been identified as recurrently altered (Knowles and Hurst, 2015; Robertson et al., 2017).”
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. (2017, positive): “NMIBC occurs mainly as papillary disease with frequent FGFR3 mutations, whereas MIBC has a more diverse mutation spectrum as well as copy-number instability (Balbas-Martinez et al., 2013; Cappellen et al., 1999; Gui et al., 2011; Knowles and Hurst, 2015; van Rhijn et al., 2001).”